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The presence or absence of a phosphorylation on a substrate at any
particular point in time is a functional readout of the balance in
activity between the regulatory kinase and the counteracting
phosphatase. Understanding how stable or short-lived a phos-
phorylation site is required for fully appreciating the biological
consequences of the phosphorylation. Our current understanding
of kinases and their substrates is well established; however, the
role phosphatases play is less understood. Therefore, we utilized a
phosphatase dependent model of mitotic exit to identify potential
substrates that are preferentially dephosphorylated. Using this
method, we identiﬁed 416,000 phosphosites on 43300 unique
proteins, and quantiﬁed the temporal phosphorylation changes
that occur during early mitotic exit (McCloy et al., 2015 [1]).
Furthermore, we annotated the majority of these phosphorylation
sites with a high conﬁdence upstream kinase using published,
motif and prediction based methods. The results from this study
have been deposited into the ProteomeXchange repository with
identiﬁer PXD001559. Here we provide additional analysis of thisvier Inc. This is an open access article under the CC BY license
rgess).
k.
S. Rogers et al. / Data in Brief 5 (2015) 45–5246dataset; for each of the major mitotic kinases we identiﬁed motifs
that correlated strongly with phosphorylation status. These motifs
could be used to predict the stability of phosphorylated residues in
proteins of interest, and help infer potential functional roles for
uncharacterized phosphorylations. In addition, we provide valida-
tion at the single cell level that serine residues phosphorylated by
Cdk are stable during phosphatase dependent mitotic exit. In
summary, this unique dataset contains information on the
temporal mitotic stability of thousands of phosphorylation sites
regulated by dozens of kinases, and information on the potential
preference that phosphatases have at both the protein and
individual phosphosite level. The compellation of this data
provides an invaluable resource for the wider research community.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Cell biologyMore speciﬁc
subject areaPhosphoproteomics and MitosisType of data MS data and annotations, western blot, time-lapse microscopy, immunoﬂuorescence
How data was
acquiredMass spectrometry (LTQ-Orbitrap Velos Pro, Thermo Fisher Scientiﬁc), Leica TCS SP8 MP confocal
microscopeData format Raw (.raw,index,.apl), ﬁltered, and analyzed data (.txt and.xlsx)
Experimental factors SILAC labeled Nocodazole arrested HeLa cells, treated with the protease inhibitor MG132, followed
with (heavy) or without (light) the Cdk1 inhibitor RO3306.
Experimental
featuresMitotic arrested and mitotic exit samples were lysed, mixed 1:1, peptides were digested with trypsin
and fractionated using strong cation exchange. Phosphopeptides were enriched using TiO2, and
samples were analyzed by LC-MS/MS.Data source location Sydney, Australia
Data accessibility All raw MaxQuant output data is available in the PRIDE repository http://www.ebi.ac.uk/pride/
archive/projects/PXD001559. Annotated spectra can be viewed using the free MS-viewer http://
prospector2.ucsf.edu with the search key gsmtp1s5q7Value of the data
 Temporal, quantitative data on over 16,000 phosphorylation sites on more than 3300 proteins.
 Majority of phosphorylation sites have been annotated with known and/or predicted upstream kinase/s, in an easy to use
excel spreadsheet, providing an excellent resource for the wider research community.
 Identiﬁcation of several new motifs for the major mitotic kinases that correlate with phosphosite stability.
 These motifs could be used to predict the potential phosphorylation stability of speciﬁc phosphorylated residues of interest.1. Data
Phosphorylation is a dynamic modiﬁcation, and therefore to fully understand the meaning of a
speciﬁc phosphorylation, its half-life must be known. The stability is an output of the activity of the
regulatory kinase and phosphatase (Fig. 1A). In order to understand the dynamic nature of
phosphorylation sites, we took advantage of the fact that during mitosis over 75% of the human
proteome (47000 proteins) is phosphorylated, with those proteins phosphorylated on the majority
of all potential phosphorylation sites [2]. As cells exit mitosis these phosphorylations are removed in a
Fig.1. (a) Shown is a simplistic model for creating stable and unstable phosphorylation sites by altering the preference that
each kinase and phosphatase pair has for a speciﬁc phosphosite. Thick arrows (black) indicate a stronger preference compared
to thin arrows. For example, sites that are preferentially dephosphorylated by a phosphatase will be unstable. (B) Schematic
diagram of method for producing highly synchronized HeLa cells undergoing phosphatase dependent mitotic exit.
(C) Schematic diagram detailing SILAC metabolic labeling of mitotic and early (phosphatase dependent) mitotic exit samples.
This was then followed by peptide digestion, fractionation, phosphopeptide enrichment, quantiﬁcation by LC-MS/MS, peptide
identiﬁcation and annotation using MaxQuant environment and ﬁnally statistical and bioinformatics analysis.
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S. Rogers et al. / Data in Brief 5 (2015) 45–5248highly organized, sequential manner [3]. Therefore, mitotic exit provides an excellent experimental
system to rapidly analyze the temporal dynamics of phosphorylation. We recently performed a global
phosphoproteomics analysis comparing mitosis to early mitotic exit [1], and here we present detailed
methods and additional data from this study. This additional information can be used by the wider
research community to infer a potential function of a phosphorylation sites based on our reported
mitotic temporal dynamics, or as predictive tool for the stability of a novel phosphorylation based
amino acids surrounding the phosphosite.2. Experimental design, materials, and methods
2.1. Cell synchrony
In order to analyze temporal events during mitotic exit, highly synchronized cell cultures are
needed. To achieve this, we utilized a two-step synchronization protocol using HeLa cells (Fig. 1B).
Brieﬂy, cells were seeded at approximately 70% conﬂuence on large 15 cm plates. They were allowed
to attached and were then treated with 1 mM Thymidine for 24 h. Cells were released from G1/S
arrest by washing 3 times with pre-warmed media, and then re-adding fresh media supplemented
with 25 mM 20-Deoxycytidine (Santa Cruz sc-231247). To capture cells in prometaphase (PM), G1/S
released cells were treated with 100 ng/ml of Nocodazole for 14 h. Further enrichment of mitotic cells
was achieved by gentle shake-off, with ﬂoating cells pooled into 50 ml falcon tubes. Mitotic cells were
then treated with 25 mMMG132 for 15 min to prevent protein degradation and to ensure cells did not
progress past metaphase. To trigger synchronized phosphatase dependent mitotic exit, enriched
mitotic cells were treated with the Cdk1 inhibitor RO3306 (10 mM).3. SILAC labeling
HeLa cells were SILAC-labeled by culturing in DMEM where the natural “light” Lysine and Arginine
were replaced by “heavy” isotope-labeled amino acids 13C615N4-L-Arginine (Arg 10) and 13C615N2-L-
Lysine (Lys 8) (Silantes GmBH), which was supplemented with 10% dialyzed FBS and 4 mM glutamine.
To ensure complete labeling of 497%, cells were cultured for approximately six doublings in heavy or
light media, with fresh media replaced every two days and sub-culturing performed when cells
reached 90% conﬂuence. After labeling, cells were synchronized as per Fig. 1B. Mitotic cells were
enriched by shake off, and both light and heavy labeled samples were treated with 25 mM MG132 for
15 min. Heavy labeled samples were then treated with 10 mM RO3306 (RO) for a further 15 min, with
both samples then harvested by centrifugation at 4 1C (Fig. 1C). Three biological replicates were
prepared, and in one replicate, the heavy/light labels were switched to provide an internal labeling
control.4. Mass spectrometry
Cells were lysed in urea lysis buffer (2.5 mM sodium pyrophosphate, 1 mM β-glycerol
phosphate, 1 mM sodium orthovanadate, 1 mM tris (2-carboxy- ethyl) phosphine (TCEP), 1 mM
EDTA, 8 M urea and 20 mM HEPES), sonicated, and then iodoacetamide was added to 100 mM.
Protein concentration was determined by the Bradford assay (Thermo Fisher Scientiﬁc, Scoresby,
VIC, Australia). Samples were then mixed 1:1 (light:heavy) based on quantiﬁcation of total protein
and digested in-solution with modiﬁed TPCK treated trypsin (Promega). Peptides were desalted on
C18 solid-phase extraction columns and separated into 9 fractions by strong-cation exchange
(SCX) using the ÄKTApuriﬁer (GE Healthcare) followed by TiO2 phosphopeptide enrichment as
previously described [4,5]. Peptides were resuspended in 0.5% acetic acid and loaded onto a laser-
drawn 30 cm, 75 mm I.D. fused silica column, packed in house with 3 mm ReproSil Pur-120
C18AQ beads (Dr. Maisch, Germany) using an Easy nLC-II (ThermoFisher Scientiﬁc) and eluted with
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lyzed on an LTQ-Orbitrap Velos Pro (Thermo Fisher Scientiﬁc) (Fig. 1C). A precursor MS scan
(350–1650 m/z) was acquired in the Orbitrap at a resolution of 60,000 followed by data-
dependent CID MS/MS in the LTQ of up to 20 most abundant precursor ions.5. Peptide identiﬁcation using MaxQuant
Mass spectra were processed with version 1.2.7.4 of the MaxQuant software package (http://www.
maxquant.org) using default settings with the inclusion of match between runs option. Peptides were
assigned incorporating modiﬁed arginine-10 and lysine-6, with a maximum of 2 missed cleavages,
using the ﬁxed modiﬁcation carboxyamidomethylation, and variable methionine oxidation and STY
phosphorylation. Database searching was performed using the Andromeda search engine integrated
into the MaxQuant environment [6] against the complete human proteome containing 88,820
sequence entries (UniProt release-2013_06, ftp://ftp.uniprot.org). Precursor mass tolerance was set at
20 ppm for initial search, fragmentation peptide to 0.6 Da. To ensure high quality protein
identiﬁcations, MS spectra were also searched against a reverse database of a similar size with the
false discovery rate limited to o1%. Known contaminants identiﬁed by MaxQuant were ﬁltered out of
the initial dataset.6. Description of dataset contained on public repositories
We have uploaded all the rawmass spectrometry data ﬁles and MaxQuant output ﬁles necessary to
reanalyze the complete dataset to the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE partner repository [7] with the identiﬁer PXD001559. Annotated
spectra can be viewed using the free MS-viewer [8] (http://prospector2.ucsf.edu) with the search key
gsmtp1s5q7. In addition, a summary of this data, in an easy to use excel spreadsheet, is provided with
this manuscript (Supplementary Table S1).7. Statistical analysis
To ensure that only highly conﬁdent protein identiﬁcations were reported, phosphosite
identiﬁcations were ﬁltered in excel for those with a localization probability greater than 0.75, a
minimum MaxQuant score of 30 and a maximum posterior error probability of 1%. A fold change
cut off of Z4 (log2 ratio Zþ2 or r2) was used to identify increased and dephosphorylated
phosphopeptides, respectively. A moderated t-test was used to identify phosphosites that are
signiﬁcantly up or down-regulated using Linear Models for Microarray and RNA-Seq Data
(LIMMA) package in R [9]. LIMMA allows for global variance shrinkage using an empirical Bayes
model. Identiﬁed sites were then corrected for multiple hypothesis testing using the Benjamini
and Hochberg method (controlling for 5% false discovery rate). Phosphopeptides were considered
to be stable if they were non-signiﬁcant proteins (adj.p.value40.05), and had log2 ratios between
0.25 and þ0.25 with a standard deviation o0.5. Supplemental Table S1 contains a summary of
all the phosphosites identiﬁed, along with moderated t-statistics, p-values and adjusted p-values
for all phosphosites.8. Data analysis
Annotation of upstream kinase was done using the reported minimal consensus motifs for each
kinase [1] and using KinomeXplorer (http://kinomexplorer.info) [10]. This information is annotated in
Supplementary Table S1. Simple data analysis of this table can be performed using Microsoft Excel and
the ﬁlter function. Sequences for each kinase for the statistically signiﬁcant dephosphorylated, and
Fig. 2. (A) Dephosphorylated (log2 o2) and stable stable (log2 0.25 to þ0.25) S/T–P phosphopeptides for each of the major
mitotic kinases were compared using IceLogo and WebLogo motif analysis software. Differentially enriched amino acids can be
identiﬁed by the increasing letter size, and distance away from center. (B) Quantitative immunoﬂuorescence of pSerCdk levels in
individual cells undergoing phosphatase dependent mitotic exit. The levels of pSerCdk are relatively stable during exit with no
signiﬁcant loss in staining is observed until cells have progressed to the late phases of exit, conﬁrming the motif observed in (A). Scale
bars¼5 mM. Shown are box plots with 5–95% conﬁdence intervals. Signiﬁcant p-values from 1-way ANOVA with Newman–Keuls
correction for multiple comparisons are shown (n¼o0.01, nn¼o0.001, nnnn¼o0.00001, n.s¼not signiﬁcant).
S. Rogers et al. / Data in Brief 5 (2015) 45–5250stable phosphosites were analyzed using motif enrichment analysis with Icelogo [11] and WebLogo 3
[12]. The results of this analysis are shown in Fig. 2A. Brieﬂy, acidic residues (D, E) upstream (right) of
the phosphorylation site are more commonly associated with stable phosphosites (Fig. 2A). Based on
our simplistic model (Fig. 1A), these acidic residues could inhibit or reduce the preference of
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tion (Fig. 1A).9. Quantitative immunoﬂuorescence staining
To validate the motifs observed in Fig. 2A, we performed quantitative immunoﬂuorescence
staining of cells undergoing phosphatase dependent mitotic exit (Fig. 2B). Cells, grown on Histogrip
(Invitrogen) coated glass coverslips, were synchronized as per Fig. 1B, and harvested using ice cold
100% methanol at 0 min (Metaphase), 15 min (Early), 30 min (Mid) 45 min (Late) and 60 min (Very
Late) post addition of the Cdk1 inhibitor RO33306. Fixed cells were washed and blocked (3% BSA, 0.1%
Tween 20 in PBS) for 30 min, then incubated with primary antibodies for pSerCdk (2324, Cell
Signaling Technologies) and β-tubulin [13] for 2 h at room temperature in blocking solution. Mouse
and Rabbit secondary Alexa 488 and 594 (Invitrogen) antibodies along with DAPI were used to
visualize pSerCdk, microtubules, and DNA respectively. Images were captured using a Leica DM5500
microscope coupled with a Coolsnap HQ2 camera, using a Leica 100X or 40X APO 1.4 lens, powered by
Leica LAS AF v3 software. To quantify pSerCdk levels in cells, a single in-focus plane was acquired
using identical microscope settings for all conditions. Analysis was performed using Image J (v1.48,
NIH) an outline drawn around each cell and circularity, area, mean ﬂuorescence measured, along with
several adjacent background readings. The Total Corrected Cellular Fluorescence (TCCF)¼ Integrated
Density – (Area of selected cellMean ﬂuorescence of background readings), was calculated. Box-
plots and statistical analysis (ordinary one-way ANOVA, with Newman–Keuls correction for multiple
comparisons) were performed using GraphPad Prism 6. For all β-tubulin and DAPI, 0.3 mm z-sections
were taken, de-convolved, and displayed as 2D maximum projections using Image J. False coloring
and overlays were performed using Adobe Photoshop CC 2015 software.Acknowledgments
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